ClearPoint Neuro Statistics Share Statistics ClearPoint Neuro has 28.27M
shares outstanding. The number of shares has increased by 2.43%
in one year.
Shares Outstanding 28.27M Shares Change (YoY) 2.43% Shares Change (QoQ) 2.29% Owned by Institutions (%) 29.56% Shares Floating 24.2M Failed to Deliver (FTD) Shares 7,062 FTD / Avg. Volume 1.71%
Short Selling Information The latest short interest is 2.07M, so 7.34% of the outstanding
shares have been sold short.
Short Interest 2.07M Short % of Shares Out 7.34% Short % of Float 7.6% Short Ratio (days to cover) 5.21
Valuation Ratios The PE ratio is -21.98 and the forward
PE ratio is -16.41.
ClearPoint Neuro's PEG ratio is
0.99.
PE Ratio -21.98 Forward PE -16.41 PS Ratio 13.24 Forward PS 6.2 PB Ratio 16.37 P/FCF Ratio -45.06 PEG Ratio 0.99
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for ClearPoint Neuro.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.22,
with a Debt / Equity ratio of 0.14.
Current Ratio 3.22 Quick Ratio 2.56 Debt / Equity 0.14 Debt / EBITDA -0.2 Debt / FCF -0.39 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $272.96K Profits Per Employee $-164.47K Employee Count 115 Asset Turnover 0.8 Inventory Turnover 1.79
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 8.38% in the
last 52 weeks. The beta is 0.85, so ClearPoint Neuro's
price volatility has been higher than the market average.
Beta 0.85 52-Week Price Change 8.38% 50-Day Moving Average 11.59 200-Day Moving Average 13.46 Relative Strength Index (RSI) 45.88 Average Volume (20 Days) 411,888
Income Statement In the last 12 months, ClearPoint Neuro had revenue of 31.39M
and earned -18.91M
in profits. Earnings per share was -0.7.
Revenue 31.39M Gross Profit 19.12M Operating Income -19.75M Net Income -18.91M EBITDA -17.84M EBIT -19.75M Earnings Per Share (EPS) -0.7
Full Income Statement Balance Sheet The company has 20.1M in cash and 3.57M in
debt, giving a net cash position of 16.54M.
Cash & Cash Equivalents 20.1M Total Debt 3.57M Net Cash 16.54M Retained Earnings -191.37M Total Assets 30.07M Working Capital 17.35M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -8.95M
and capital expenditures -275K, giving a free cash flow of -9.22M.
Operating Cash Flow -8.95M Capital Expenditures -275K Free Cash Flow -9.22M FCF Per Share -0.34
Full Cash Flow Statement Margins Gross margin is 60.92%, with operating and profit margins of -62.91% and -60.25%.
Gross Margin 60.92% Operating Margin -62.91% Pretax Margin -60.25% Profit Margin -60.25% EBITDA Margin -56.84% EBIT Margin -62.91% FCF Margin -29.39%
Dividends & Yields CLPT does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for CLPT is $28,
which is 164.2% higher than the current price. The consensus rating is "Strong Buy".
Price Target $28 Price Target Difference 164.2% Analyst Consensus Strong Buy Analyst Count 3
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 27, 2016. It was a
backward
split with a ratio of 1:40.
Last Split Date Jul 27, 2016 Split Type backward Split Ratio 1:40
Scores Altman Z-Score 8.56 Piotroski F-Score 4
